Chinese Biotech Breakthroughs

Results

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

6 companies

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥25.2b

Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.

688266

CN¥95.37

-1.7%

56.1%

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥30.9b

A biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases.

688192

CN¥66.94

8.0%

67.6%

Shanghai Rightongene Biotechnology

Market Cap: CN¥1.7b

Shanghai Rightongene Biotechnology Co., Ltd.

688217

CN¥30.47

7.0%

66.0%

Chongqing Zhifei Biological Products

Market Cap: CN¥48.1b

Chongqing Zhifei Biological Products Co., Ltd.

300122

CN¥20.08

3.3%

-18.0%

Shenzhen Kangtai Biological Products

Market Cap: CN¥18.0b

Shenzhen Kangtai Biological Products Co., Ltd.

300601

CN¥16.16

5.3%

8.2%

Nanjing Vazyme Biotech

Market Cap: CN¥8.7b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

688105

CN¥21.85

6.6%

8.4%